Company Filing History:
Years Active: 2007-2011
Title: Tinka Tuinstra: Innovator in Pharmaceutical Chemistry
Introduction
Tinka Tuinstra is a notable inventor based in Weesp, Netherlands. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target human ORL1 receptors. With a total of 3 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
Tuinstra's latest patents include innovative compounds such as benzimidazolone and quinazolinone derivatives that act as agonists on human ORL1 receptors. These inventions focus on a group of novel derivatives that can be utilized in pharmaceutical compositions for treating disorders associated with ORL1 receptors. Another significant patent involves hydronopol substituted benzimidazolone and quinazolinone derivatives, which also serve as agonists on human ORL1 receptors. Both patents emphasize the preparation of these compounds and their potential therapeutic applications.
Career Highlights
Tinka Tuinstra is currently associated with Solvay Pharmaceuticals B.V., where she continues to explore and develop innovative pharmaceutical solutions. Her work has been instrumental in advancing the understanding of ORL1 receptor interactions and their implications in various medical conditions.
Collaborations
Throughout her career, Tuinstra has collaborated with esteemed colleagues such as Herman H Van Stuivenberg and Jacobus A J Den Hartog. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Tinka Tuinstra's contributions to pharmaceutical chemistry are noteworthy, particularly her innovative work on ORL1 receptor agonists. Her patents reflect a commitment to advancing medical science and improving treatment options for patients.